These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27002689)

  • 1. Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections.
    d'Angelo I; Perfetto B; Costabile G; Ambrosini V; Caputo P; Miro A; d'Emmanuele di Villa Bianca R; Sorrentino R; Donnarumma G; Quaglia F; Ungaro F
    Biomacromolecules; 2016 May; 17(5):1561-71. PubMed ID: 27002689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEI-engineered respirable particles delivering a decoy oligonucleotide to NF-κB: inhibiting MUC2 expression in LPS-stimulated airway epithelial cells.
    Ungaro F; De Stefano D; Giovino C; Masuccio A; Miro A; Sorrentino R; Carnuccio R; Quaglia F
    PLoS One; 2012; 7(10):e46457. PubMed ID: 23056313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decoy oligonucleotide to NF-κB delivered through inhalable particles prevents LPS-induced rat airway inflammation.
    De Stefano D; Coletta C; Bianca Rd; Falcone L; d'Angelo I; Ungaro F; Quaglia F; Carnuccio R; Sorrentino R
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):288-95. PubMed ID: 23590300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
    Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat.
    De Stefano D; De Rosa G; Maiuri MC; Ungaro F; Quaglia F; Iuvone T; Cinelli MP; La Rotonda MI; Carnuccio R
    Pharmacol Res; 2009 Jul; 60(1):33-40. PubMed ID: 19427583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolizable modified-release particles of montelukast improve retention and availability of the drug in the lungs.
    Patel B; Rashid J; Ahsan F
    Eur J Pharm Sci; 2017 Jan; 96():560-570. PubMed ID: 27989858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming barriers in Pseudomonas aeruginosa lung infections: Engineered nanoparticles for local delivery of a cationic antimicrobial peptide.
    d'Angelo I; Casciaro B; Miro A; Quaglia F; Mangoni ML; Ungaro F
    Colloids Surf B Biointerfaces; 2015 Nov; 135():717-725. PubMed ID: 26340361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
    Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
    J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of PEI as a core modifying agent on PLGA microspheres of PGE₁, a pulmonary selective vasodilator.
    Gupta V; Ahsan F
    Int J Pharm; 2011 Jul; 413(1-2):51-62. PubMed ID: 21530623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porous PLGA scaffolds for controlled release of naked and polyethyleneimine-complexed DNA.
    Ravi N; Gupta G; Milbrandt TA; Puleo DA
    Biomed Mater; 2012 Oct; 7(5):055007. PubMed ID: 22909549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and characterisation of poly(lactide-co-glycolide) small particulate systems for the delivery of immunostimulant CpG oligonucleotide.
    Shakweh M; Fattal E
    J Nanosci Nanotechnol; 2006; 6(9-10):2811-20. PubMed ID: 17048487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Hansen C; Skov M
    Ther Adv Respir Dis; 2015 Feb; 9(1):16-21. PubMed ID: 25471692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
    Rashid J; Patel B; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
    J Control Release; 2017 Mar; 250():96-106. PubMed ID: 28185800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
    Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
    J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.
    Kuo YC; Yu HW
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):158-64. PubMed ID: 21764569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.
    Costabile G; d'Angelo I; Rampioni G; Bondì R; Pompili B; Ascenzioni F; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Miro A; Quaglia F; Imperi F; Leoni L; Ungaro F
    Mol Pharm; 2015 Aug; 12(8):2604-17. PubMed ID: 25974285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
    De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
    J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.